Syed Faheem Ali

Company Overview: Medtech startup where we developed an innovative cartilage-on-a-chip platform and gene expression analysis system for osteoarthritis (OA) and organ-on-chip applications in OA research

• Help and assist the company in securing over €2 million in public grants for multiple projects, overseeing milestone fulfillment and ensuring timely reporting to funding agencies
• Developed key operational initiatives to drive and maintain substantial business growth.
• Increased the throughput of Pregenerate's cartilage-on-a-chip platform by 5× by developing a high-throughput microfluidic chip based on a 96-well plate, enabling analysis of a full patient sample on a single chip instead of five
• Conducted target market research to scope out industry competition and identify advantageous trends.
• Oversaw talent acquisition efforts, building a diverse team of skilled professionals who contributed significantly to the company''s success.
• Established and streamlined the supply chain by coordinating with manufacturers and vendors, ensuring seamless service delivery and operations
• Designed and implemented OKRs and KPIs based on market analysis and shareholder feedback to drive organizational performance and strategic alignment
• Communicated business performance, forecasts, and strategies to shareholders through comprehensive presentations and regular KPI reporting
• Worked closely with the Chief Marketing Officer (CMO) to adopt and update the business plan, aligning it with market trends and company goals
• Developed and optimized internal company processes, including procedures for ordering, shareholder reporting, and financial forecasting, improving operational efficiency
• Collaborated with regulatory experts to design and implement ISO 15139 compliance, ensuring adherence to industry standards
• Medtech startup

• µfluidic Chip designing, fabrication and optimization
• Biosensors fabrication, Integration and modification
• Development of self-powered lab-on-a-chip system for detection of viral infections in biofluids